{
  "schema_version": "2.0",
  "doc_id": "5b84b472f8f855e4c510c7ee874bbc73d75984ba76cde2c4f99bd05c36dbbb11",
  "extracted_at": "2026-02-01T08:28:05.427112+00:00",
  "extractor": "legacy-migration",
  "entities": [
    {
      "id": "ent_001",
      "type": "Taxon",
      "name": "S. tortuosum",
      "attributes": {
        "context": "milled S. tortuosum raw material"
      },
      "source_chunk_ids": [
        "bcd19bffd9b31efb17410d9ab6a98f0d"
      ]
    },
    {
      "id": "ent_002",
      "type": "PharmEffect",
      "name": "antidepressant activity",
      "attributes": {
        "context": "antidepressant and anxiolytic activity"
      },
      "source_chunk_ids": [
        "bcd19bffd9b31efb17410d9ab6a98f0d"
      ]
    },
    {
      "id": "ent_003",
      "type": "PharmEffect",
      "name": "anxiolytic activity",
      "attributes": {
        "context": "antidepressant and anxiolytic activity"
      },
      "source_chunk_ids": [
        "bcd19bffd9b31efb17410d9ab6a98f0d"
      ]
    },
    {
      "id": "ent_004",
      "type": "Indication",
      "name": "major depression",
      "attributes": {
        "context": "suffering from major depression"
      },
      "source_chunk_ids": [
        "bcd19bffd9b31efb17410d9ab6a98f0d"
      ]
    },
    {
      "id": "ent_005",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {
        "context": "blockade of the serotonin (5-HT) transporter"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_006",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {
        "context": "blockade of the serotonin (5-HT) transporter"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_007",
      "type": "Compound",
      "name": "phosphodiesterase-4",
      "attributes": {
        "context": "inhibition of the phosphodiesterase-4 (PDE4) enzyme"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_008",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "inhibition of the phosphodiesterase-4 (PDE4) enzyme"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_009",
      "type": "Compound",
      "name": "5-HT reuptake inhibitors",
      "attributes": {
        "context": "5-HT reuptake inhibitors (SSRIs) are widely used"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_010",
      "type": "Compound",
      "name": "SSRIs",
      "attributes": {
        "context": "5-HT reuptake inhibitors (SSRIs) are widely used"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_011",
      "type": "Compound",
      "name": "PDE4 inhibitor",
      "attributes": {
        "context": "combination of SSRIs with a PDE4 inhibitor"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_012",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "can upregulate PDE4"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_013",
      "type": "Compound",
      "name": "SSRIs",
      "attributes": {
        "context": "reduces the sensitivity to SSRIs"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_014",
      "type": "Compound",
      "name": "SSRIs",
      "attributes": {
        "context": "dual treatment with SSRIs and PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_015",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "dual treatment with SSRIs and PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_016",
      "type": "Taxon",
      "name": "S. tortuosum",
      "attributes": {
        "context": "extract of S. tortuosum (Zembrin)"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_017",
      "type": "PharmEffect",
      "name": "blockade of the serotonin (5-HT) transporter",
      "attributes": {
        "context": "comprising blockade of the serotonin (5-HT) transporter"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_018",
      "type": "PharmEffect",
      "name": "selective inhibition of the phosphodiesterase-4 (PDE4) enzyme",
      "attributes": {
        "context": "selective inhibition of the phosphodiesterase-4 (PDE4) enzyme"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_019",
      "type": "PharmEffect",
      "name": "synergistic therapeutic potential",
      "attributes": {
        "context": "synergistic therapeutic potential in CNS disorders"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_020",
      "type": "PharmEffect",
      "name": "greater symptomatic efficacy",
      "attributes": {
        "context": "providing greater symptomatic efficacy"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_021",
      "type": "PharmEffect",
      "name": "broader therapeutic utility",
      "attributes": {
        "context": "broader therapeutic utility than either as a drug"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_022",
      "type": "PharmEffect",
      "name": "upregulate PDE4",
      "attributes": {
        "context": "can upregulate PDE4"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_023",
      "type": "PharmEffect",
      "name": "reduces the sensitivity to SSRIs",
      "attributes": {
        "context": "reduces the sensitivity to SSRIs"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_024",
      "type": "Indication",
      "name": "anxiety disorders",
      "attributes": {
        "context": "treatment of anxiety disorders and depression"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_025",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "treatment of anxiety disorders and depression"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_026",
      "type": "Indication",
      "name": "CNS disorders",
      "attributes": {
        "context": "therapeutic potential in CNS disorders"
      },
      "source_chunk_ids": [
        "79859a5283190f5c39c0f45bddac6d45"
      ]
    },
    {
      "id": "ent_027",
      "type": "Compound",
      "name": "purified water",
      "attributes": {
        "context": "purified water 30% V/V"
      },
      "source_chunk_ids": [
        "4fef5ab7d8ba792595e86a69f7ddb62f"
      ]
    },
    {
      "id": "ent_028",
      "type": "Compound",
      "name": "ethanol",
      "attributes": {
        "context": "ethanol 70% V/V"
      },
      "source_chunk_ids": [
        "4fef5ab7d8ba792595e86a69f7ddb62f"
      ]
    },
    {
      "id": "ent_029",
      "type": "Compound",
      "name": "maltodextrin",
      "attributes": {
        "context": "maltodextrin carrier"
      },
      "source_chunk_ids": [
        "4fef5ab7d8ba792595e86a69f7ddb62f"
      ]
    },
    {
      "id": "ent_030",
      "type": "Taxon",
      "name": "S. tortuosum",
      "attributes": {
        "context": "South African plant S. tortuosum"
      },
      "source_chunk_ids": [
        "4fef5ab7d8ba792595e86a69f7ddb62f"
      ]
    },
    {
      "id": "ent_031",
      "type": "Compound",
      "name": "alkaloids",
      "attributes": {
        "context": "four active alkaloids"
      },
      "source_chunk_ids": [
        "4fef5ab7d8ba792595e86a69f7ddb62f"
      ]
    },
    {
      "id": "ent_032",
      "type": "Compound",
      "name": "mesembrenone",
      "attributes": {
        "context": "mesembrenone"
      },
      "source_chunk_ids": [
        "4fef5ab7d8ba792595e86a69f7ddb62f"
      ]
    },
    {
      "id": "ent_033",
      "type": "Compound",
      "name": "mesembrenol",
      "attributes": {
        "context": "mesembrenol"
      },
      "source_chunk_ids": [
        "4fef5ab7d8ba792595e86a69f7ddb62f"
      ]
    },
    {
      "id": "ent_034",
      "type": "Compound",
      "name": "mesembranol",
      "attributes": {
        "context": "mesembranol"
      },
      "source_chunk_ids": [
        "4fef5ab7d8ba792595e86a69f7ddb62f"
      ]
    },
    {
      "id": "ent_035",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "mesembrine"
      },
      "source_chunk_ids": [
        "4fef5ab7d8ba792595e86a69f7ddb62f"
      ]
    },
    {
      "id": "ent_036",
      "type": "Compound",
      "name": "Zembrin",
      "attributes": {
        "context": "25 mg of Zembrin"
      },
      "source_chunk_ids": [
        "f146a09e48a40edc7b10ee3d64318dcd"
      ]
    },
    {
      "id": "ent_037",
      "type": "Compound",
      "name": "inert excipients",
      "attributes": {
        "context": "together with inert excipients"
      },
      "source_chunk_ids": [
        "f146a09e48a40edc7b10ee3d64318dcd"
      ]
    },
    {
      "id": "ent_038",
      "type": "Compound",
      "name": "inert excipients",
      "attributes": {
        "context": "contained only inert excipients"
      },
      "source_chunk_ids": [
        "f146a09e48a40edc7b10ee3d64318dcd"
      ]
    },
    {
      "id": "ent_039",
      "type": "Taxon",
      "name": "S. tortuosum",
      "attributes": {
        "context": "above-ground S. tortuosum plant material"
      },
      "source_chunk_ids": [
        "f146a09e48a40edc7b10ee3d64318dcd"
      ]
    },
    {
      "id": "ent_040",
      "type": "Concentration",
      "name": "25 mg of Zembrin",
      "attributes": {
        "context": "contained 25 mg of Zembrin"
      },
      "source_chunk_ids": [
        "f146a09e48a40edc7b10ee3d64318dcd"
      ]
    },
    {
      "id": "ent_041",
      "type": "Concentration",
      "name": "50 mg of dry raw above-ground S. tortuosum plant material",
      "attributes": {
        "context": "equivalent to 50 mg of dry raw above-ground S. tortuosum plant material"
      },
      "source_chunk_ids": [
        "f146a09e48a40edc7b10ee3d64318dcd"
      ]
    },
    {
      "id": "ent_042",
      "type": "Compound",
      "name": "Zembrin",
      "attributes": {
        "context": "scanned once after Zembrin"
      },
      "source_chunk_ids": [
        "932f5c545e6c8ab8ffc64ff066df0d5d"
      ]
    },
    {
      "id": "ent_043",
      "type": "PharmEffect",
      "name": "mood changes",
      "attributes": {
        "context": "report any mood changes"
      },
      "source_chunk_ids": [
        "932f5c545e6c8ab8ffc64ff066df0d5d"
      ]
    },
    {
      "id": "ent_044",
      "type": "PharmEffect",
      "name": "side effects",
      "attributes": {
        "context": "or side effects"
      },
      "source_chunk_ids": [
        "932f5c545e6c8ab8ffc64ff066df0d5d"
      ]
    },
    {
      "id": "ent_045",
      "type": "Compound",
      "name": "Mesembrenol",
      "attributes": {
        "context": "Chemical structures of four mesembrine alkaloids: Mesembrenol"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_046",
      "type": "Compound",
      "name": "Mesembrenone",
      "attributes": {
        "context": "Chemical structures of four mesembrine alkaloids: Mesembrenol, Mesembrenone"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_047",
      "type": "Compound",
      "name": "Mesembrine",
      "attributes": {
        "context": "Chemical structures of four mesembrine alkaloids: Mesembrenol, Mesembrenone, Mesembrine"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_048",
      "type": "Compound",
      "name": "Mesembranol",
      "attributes": {
        "context": "Chemical structures of four mesembrine alkaloids: Mesembrenol, Mesembrenone, Mesembrine, and Mesembranol"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_049",
      "type": "Compound",
      "name": "mesembrine alkaloids",
      "attributes": {
        "context": "four mesembrine alkaloids"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_050",
      "type": "Compound",
      "name": "1,2,3,4-tetrahydroisoquinoline core",
      "attributes": {
        "context": "a 1,2,3,4-tetrahydroisoquinoline core"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_051",
      "type": "Compound",
      "name": "3,4-dimethoxyphenyl group",
      "attributes": {
        "context": "a 3,4-dimethoxyphenyl group at the 1-position"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_052",
      "type": "Compound",
      "name": "hydroxyl group",
      "attributes": {
        "context": "Mesembrenol has a hydroxyl group at the 2-position"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_053",
      "type": "Compound",
      "name": "ketone group",
      "attributes": {
        "context": "Mesembrenone has a ketone group at the 2-position"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_054",
      "type": "Compound",
      "name": "methyl group",
      "attributes": {
        "context": "Mesembrine has a methyl group at the 2-position"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_055",
      "type": "Compound",
      "name": "hydroxyl group",
      "attributes": {
        "context": "Mesembranol has a hydroxyl group at the 2-position"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_056",
      "type": "Compound",
      "name": "methyl group",
      "attributes": {
        "context": "Mesembranol has a hydroxyl group at the 2-position and a methyl group at the 3-position"
      },
      "source_chunk_ids": [
        "c34aef509de734bc270ac325d1be1991"
      ]
    },
    {
      "id": "ent_057",
      "type": "Compound",
      "name": "Zembrin",
      "attributes": {
        "context": "DRUG (Zembrin versus placebo)"
      },
      "source_chunk_ids": [
        "fb60c9c0b70713103205f79e07c7af06"
      ]
    },
    {
      "id": "ent_058",
      "type": "Compound",
      "name": "placebo",
      "attributes": {
        "context": "DRUG (Zembrin versus placebo)"
      },
      "source_chunk_ids": [
        "fb60c9c0b70713103205f79e07c7af06"
      ]
    },
    {
      "id": "ent_059",
      "type": "PharmEffect",
      "name": "anxiety-related",
      "attributes": {
        "context": "anxiety-related amygdala reactivity"
      },
      "source_chunk_ids": [
        "0e7802a533907fb4715b29659d80c8cd"
      ]
    },
    {
      "id": "ent_060",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "anxiety-related amygdala reactivity"
      },
      "source_chunk_ids": [
        "0e7802a533907fb4715b29659d80c8cd"
      ]
    },
    {
      "id": "ent_061",
      "type": "PharmEffect",
      "name": "DRUG effects",
      "attributes": {
        "context": "test for DRUG effects"
      },
      "source_chunk_ids": [
        "0e7802a533907fb4715b29659d80c8cd"
      ]
    },
    {
      "id": "ent_062",
      "type": "Compound",
      "name": "Zembrin",
      "attributes": {
        "context": "For High Load, both Zembrin and Placebo show high error rates"
      },
      "source_chunk_ids": [
        "e003158b77036d01f3aae2bd3f143b75"
      ]
    },
    {
      "id": "ent_063",
      "type": "Compound",
      "name": "placebo",
      "attributes": {
        "context": "compared with placebo"
      },
      "source_chunk_ids": [
        "413116c0769258ce05bddb71240cb603"
      ]
    },
    {
      "id": "ent_064",
      "type": "Compound",
      "name": "Zembrin",
      "attributes": {
        "context": "after Zembrin compared with placebo administration"
      },
      "source_chunk_ids": [
        "57e11667ffaf4c2e7d9e67526c27cf87"
      ]
    },
    {
      "id": "ent_065",
      "type": "Compound",
      "name": "placebo",
      "attributes": {
        "context": "compared with placebo administration"
      },
      "source_chunk_ids": [
        "57e11667ffaf4c2e7d9e67526c27cf87"
      ]
    },
    {
      "id": "ent_066",
      "type": "PharmEffect",
      "name": "decreased functional connectivity",
      "attributes": {
        "context": "the amygdala showed overall decreased functional connectivity with the hypothalamus"
      },
      "source_chunk_ids": [
        "57e11667ffaf4c2e7d9e67526c27cf87"
      ]
    },
    {
      "id": "ent_067",
      "type": "PharmEffect",
      "name": "reduced amygdala\u2013hypothalamus connectivity",
      "attributes": {
        "context": "the reduced amygdala\u2013hypothalamus connectivity was marginally larger"
      },
      "source_chunk_ids": [
        "57e11667ffaf4c2e7d9e67526c27cf87"
      ]
    },
    {
      "id": "ent_068",
      "type": "Compound",
      "name": "Zembrin",
      "attributes": {
        "context": "single administration of Zembrin"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_069",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "dual PDE4 and 5-HT reuptake inhibitor"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_070",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {
        "context": "dual PDE4 and 5-HT reuptake inhibitor"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_071",
      "type": "Taxon",
      "name": "Sceletium tortuosum",
      "attributes": {
        "context": "S. tortuosum extract"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_072",
      "type": "PharmEffect",
      "name": "dual PDE4 and 5-HT reuptake inhibitor",
      "attributes": {
        "context": "characterized as a dual PDE4 and 5-HT reuptake inhibitor"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_073",
      "type": "Compound",
      "name": "placebo",
      "attributes": {
        "context": "Zembrin compared with placebo administration"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_074",
      "type": "PharmEffect",
      "name": "reduces anxiety-related amygdala reactivity",
      "attributes": {
        "context": "reduces anxiety-related amygdala reactivity"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_075",
      "type": "PharmEffect",
      "name": "attenuates amygdala\u2013hypothalamus coupling",
      "attributes": {
        "context": "attenuates amygdala\u2013hypothalamus coupling"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_076",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "anxiety-related amygdala reactivity"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_077",
      "type": "PharmEffect",
      "name": "dampening effects",
      "attributes": {
        "context": "dampening effects of Zembrin"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_078",
      "type": "Indication",
      "name": "anxiety disorders",
      "attributes": {
        "context": "treatment of anxiety disorders"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_079",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "treatment of anxiety disorders and depression"
      },
      "source_chunk_ids": [
        "656e73965f25e14ad688fa3ff6a9a51a"
      ]
    },
    {
      "id": "ent_080",
      "type": "Indication",
      "name": "Anxiety",
      "attributes": {
        "context": "Anxiety is characterized by hyper-responsivity"
      },
      "source_chunk_ids": [
        "c076a9c64f24a2a0fa881de9a0ff87cc"
      ]
    },
    {
      "id": "ent_081",
      "type": "Indication",
      "name": "anxious",
      "attributes": {
        "context": "clinically anxious individuals"
      },
      "source_chunk_ids": [
        "c076a9c64f24a2a0fa881de9a0ff87cc"
      ]
    },
    {
      "id": "ent_082",
      "type": "Indication",
      "name": "state anxiety",
      "attributes": {
        "context": "increased by state anxiety"
      },
      "source_chunk_ids": [
        "c076a9c64f24a2a0fa881de9a0ff87cc"
      ]
    },
    {
      "id": "ent_083",
      "type": "Taxon",
      "name": "Sceletium tortuosum",
      "attributes": {
        "context": "anxiolytic properties of S. tortuosum"
      },
      "source_chunk_ids": [
        "c076a9c64f24a2a0fa881de9a0ff87cc"
      ]
    },
    {
      "id": "ent_084",
      "type": "PharmEffect",
      "name": "anxiolytic",
      "attributes": {
        "context": "anxiolytic properties of S. tortuosum"
      },
      "source_chunk_ids": [
        "c076a9c64f24a2a0fa881de9a0ff87cc"
      ]
    },
    {
      "id": "ent_085",
      "type": "Indication",
      "name": "state anxiety",
      "attributes": {
        "context": "independent from state anxiety"
      },
      "source_chunk_ids": [
        "c076a9c64f24a2a0fa881de9a0ff87cc"
      ]
    },
    {
      "id": "ent_086",
      "type": "PharmEffect",
      "name": "Attenuation of threat responsivity",
      "attributes": {
        "context": "Attenuation of threat responsivity, as measured with the BOLD signal"
      },
      "source_chunk_ids": [
        "14f935f8e751d315efb905b37a223740"
      ]
    },
    {
      "id": "ent_087",
      "type": "Compound",
      "name": "Zembrin",
      "attributes": {
        "context": "after Zembrin administration"
      },
      "source_chunk_ids": [
        "14f935f8e751d315efb905b37a223740"
      ]
    },
    {
      "id": "ent_088",
      "type": "Indication",
      "name": "anxiety-related behaviors",
      "attributes": {
        "context": "involved in anxiety-related behaviors"
      },
      "source_chunk_ids": [
        "14f935f8e751d315efb905b37a223740"
      ]
    },
    {
      "id": "ent_089",
      "type": "PharmEffect",
      "name": "anxiolytic",
      "attributes": {
        "context": "anxiolytic actions"
      },
      "source_chunk_ids": [
        "4544b3c0457a9a53dc094ea36a34fdc4"
      ]
    },
    {
      "id": "ent_090",
      "type": "Compound",
      "name": "Zembrin",
      "attributes": {
        "context": "actions of Zembrin"
      },
      "source_chunk_ids": [
        "4544b3c0457a9a53dc094ea36a34fdc4"
      ]
    },
    {
      "id": "ent_091",
      "type": "PharmEffect",
      "name": "anxiolytic potential",
      "attributes": {
        "context": "support for the anxiolytic potential"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_092",
      "type": "Compound",
      "name": "5-HT reuptake inhibitors",
      "attributes": {
        "context": "dual 5-HT reuptake and PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_093",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "dual 5-HT reuptake and PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_094",
      "type": "PharmEffect",
      "name": "synergistic potential",
      "attributes": {
        "context": "have synergistic potential"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_095",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "treatment of anxiety and depression"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_096",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "treatment of anxiety and depression"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_097",
      "type": "PharmEffect",
      "name": "reduce side effects",
      "attributes": {
        "context": "used to reduce side effects"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_098",
      "type": "Compound",
      "name": "SSRI",
      "attributes": {
        "context": "Acute SSRI administration"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_099",
      "type": "PharmEffect",
      "name": "increase amygdala reactivity",
      "attributes": {
        "context": "increase amygdala reactivity"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_100",
      "type": "PharmEffect",
      "name": "reduces amygdala reactivity",
      "attributes": {
        "context": "generally reduces amygdala reactivity"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_101",
      "type": "PharmEffect",
      "name": "increased agitation",
      "attributes": {
        "context": "effect of increased agitation"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_102",
      "type": "PharmEffect",
      "name": "increased sensitivity for social information",
      "attributes": {
        "context": "increased sensitivity for social information"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_103",
      "type": "Compound",
      "name": "SSRIs",
      "attributes": {
        "context": "after first use of SSRIs"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_104",
      "type": "PharmEffect",
      "name": "anxiolytic properties",
      "attributes": {
        "context": "anxiolytic properties of SSRIs"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_105",
      "type": "Compound",
      "name": "SSRIs",
      "attributes": {
        "context": "anxiolytic properties of SSRIs"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_106",
      "type": "PharmEffect",
      "name": "reduction of amygdala reactivity",
      "attributes": {
        "context": "the reduction of amygdala reactivity"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_107",
      "type": "Indication",
      "name": "state anxiety",
      "attributes": {
        "context": "linked to state anxiety"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_108",
      "type": "Compound",
      "name": "Zembrin",
      "attributes": {
        "context": "long-term Zembrin administration"
      },
      "source_chunk_ids": [
        "51a599c1831b3ac45f6c742e3d0a2cb4"
      ]
    },
    {
      "id": "ent_109",
      "type": "Compound",
      "name": "Zembrin",
      "attributes": {
        "context": "inhibitor Zembrin reduces"
      },
      "source_chunk_ids": [
        "4853c671e27e4969aa77e0ea192a0118"
      ]
    },
    {
      "id": "ent_110",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {
        "context": "dual 5-HT reuptake"
      },
      "source_chunk_ids": [
        "4853c671e27e4969aa77e0ea192a0118"
      ]
    },
    {
      "id": "ent_111",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "and PDE4 inhibitor"
      },
      "source_chunk_ids": [
        "4853c671e27e4969aa77e0ea192a0118"
      ]
    },
    {
      "id": "ent_112",
      "type": "Indication",
      "name": "fear",
      "attributes": {
        "context": "unattended facial fear"
      },
      "source_chunk_ids": [
        "4853c671e27e4969aa77e0ea192a0118"
      ]
    },
    {
      "id": "ent_113",
      "type": "PharmEffect",
      "name": "anxiolytic",
      "attributes": {
        "context": "potential anxiolytic actions"
      },
      "source_chunk_ids": [
        "4853c671e27e4969aa77e0ea192a0118"
      ]
    },
    {
      "id": "ent_114",
      "type": "Taxon",
      "name": "Sceletium tortuosum",
      "attributes": {
        "context": "extract of Sceletium tortuosum (Zembrin)"
      },
      "source_chunk_ids": [
        "80aa3045640a2a8e39d0cec4d575193a"
      ]
    },
    {
      "id": "ent_115",
      "type": "Taxon",
      "name": "Zembrin",
      "attributes": {
        "context": "extract of Sceletium tortuosum (Zembrin)"
      },
      "source_chunk_ids": [
        "80aa3045640a2a8e39d0cec4d575193a"
      ]
    },
    {
      "id": "ent_116",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {
        "context": "Assessing human 5-HT function"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_117",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "attentional bias in anxious and nonanxious individuals"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_118",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {
        "context": "Acute 5-HT reuptake blockade"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_119",
      "type": "PharmEffect",
      "name": "reuptake blockade",
      "attributes": {
        "context": "Acute 5-HT reuptake blockade potentiates"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_120",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "effects of anxiety are gated"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_121",
      "type": "Compound",
      "name": "phosphodiesterase-4 inhibitor",
      "attributes": {
        "context": "by the phosphodiesterase-4 inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_122",
      "type": "Compound",
      "name": "6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline",
      "attributes": {
        "context": "inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_123",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {
        "context": "inhibition of serotonin re-uptake"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_124",
      "type": "Compound",
      "name": "phosphodiesterase",
      "attributes": {
        "context": "and phosphodiesterase by dual inhibitors"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_125",
      "type": "PharmEffect",
      "name": "inhibition",
      "attributes": {
        "context": "Stereoselective inhibition of serotonin re-uptake"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_126",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "agents for depression"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_127",
      "type": "Compound",
      "name": "Cyclic AMP phosphodiesterases",
      "attributes": {
        "context": "Cyclic AMP phosphodiesterases are localized"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_128",
      "type": "Compound",
      "name": "citalopram",
      "attributes": {
        "context": "effect of citalopram pretreatment"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_129",
      "type": "PharmEffect",
      "name": "antidepressant",
      "attributes": {
        "context": "and antidepressant treatment"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_130",
      "type": "Compound",
      "name": "serotonin 1A receptor",
      "attributes": {
        "context": "Medial prefrontal cortex serotonin 1A and 2A receptor binding"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_131",
      "type": "Compound",
      "name": "serotonin 2A receptor",
      "attributes": {
        "context": "serotonin 1A and 2A receptor binding"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_132",
      "type": "Indication",
      "name": "Anxiety Disorder",
      "attributes": {
        "context": "Biol Mood Anxiety Disord"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_133",
      "type": "Compound",
      "name": "cAMP-phosphodiesterase inhibitor",
      "attributes": {
        "context": "new cAMP-phosphodiesterase inhibitor rolipram"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_134",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "inhibitor rolipram in patients"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_135",
      "type": "Indication",
      "name": "major depressive disorder",
      "attributes": {
        "context": "with major depressive disorder"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_136",
      "type": "Indication",
      "name": "social anxiety disorder",
      "attributes": {
        "context": "Neuroimaging in social anxiety disorder"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_137",
      "type": "Compound",
      "name": "phosphodiesterase type IV",
      "attributes": {
        "context": "brain phosphodiesterase type IV measured"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_138",
      "type": "Compound",
      "name": "11C-(R)-rolipram",
      "attributes": {
        "context": "measured with 11C-(R)-rolipram positron emission tomography"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_139",
      "type": "Indication",
      "name": "major depressive disorder",
      "attributes": {
        "context": "in major depressive disorder"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_140",
      "type": "Taxon",
      "name": "South African medicinal plants",
      "attributes": {
        "context": "selected South African medicinal plants"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_141",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "Sceletium\u2014a review update"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_142",
      "type": "Compound",
      "name": "PDE inhibitors",
      "attributes": {
        "context": "PDE inhibitors in psychiatry"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_143",
      "type": "Indication",
      "name": "dementia",
      "attributes": {
        "context": "options for dementia, depression and schizophrenia"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_144",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "dementia, depression and schizophrenia"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_145",
      "type": "Indication",
      "name": "schizophrenia",
      "attributes": {
        "context": "depression and schizophrenia"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_146",
      "type": "Compound",
      "name": "Serotonin transporter",
      "attributes": {
        "context": "Serotonin transporter genetic variation"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_147",
      "type": "PharmEffect",
      "name": "antidepressants",
      "attributes": {
        "context": "Why do antidepressants take so long to work?"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_148",
      "type": "PharmEffect",
      "name": "antidepressant",
      "attributes": {
        "context": "model of antidepressant drug action"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_149",
      "type": "Taxon",
      "name": "Sceletium tortuosum",
      "attributes": {
        "context": "food plant Sceletium tortuosum and its principal alkaloids"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_150",
      "type": "Compound",
      "name": "alkaloids",
      "attributes": {
        "context": "and its principal alkaloids"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_151",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "to pathological anxiety"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_152",
      "type": "Compound",
      "name": "Oxytocin",
      "attributes": {
        "context": "Oxytocin modulates neural circuitry"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_153",
      "type": "Compound",
      "name": "cyclic AMP-phosphodiesterase-4",
      "attributes": {
        "context": "Cortico-striatal cyclic AMP-phosphodiesterase-4 signalling"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_154",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {
        "context": "after chronic fluoxetine treatment"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_155",
      "type": "PharmEffect",
      "name": "Antidepressant-like effects",
      "attributes": {
        "context": "Antidepressant- and anxiolytic-like effects"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_156",
      "type": "PharmEffect",
      "name": "anxiolytic-like effects",
      "attributes": {
        "context": "Antidepressant- and anxiolytic-like effects"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_157",
      "type": "Compound",
      "name": "phosphodiesterase-4 inhibitor",
      "attributes": {
        "context": "of the phosphodiesterase-4 inhibitor rolipram"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_158",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "inhibitor rolipram on behavior"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_159",
      "type": "Compound",
      "name": "cyclic AMP response element binding protein",
      "attributes": {
        "context": "depend on cyclic AMP response element binding protein-mediated neurogenesis"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_160",
      "type": "PharmEffect",
      "name": "Antidepressant medications",
      "attributes": {
        "context": "Antidepressant medications reduce subcortical-cortical"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_161",
      "type": "Compound",
      "name": "citalopram",
      "attributes": {
        "context": "single dose of citalopram"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_162",
      "type": "Concentration",
      "name": "single dose",
      "attributes": {
        "context": "Effect of a single dose of citalopram"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_163",
      "type": "Taxon",
      "name": "Sceletium tortuosum",
      "attributes": {
        "context": "extract Sceletium tortuosum (Zembrin\u00ae)"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_164",
      "type": "Compound",
      "name": "Zembrin\u00ae",
      "attributes": {
        "context": "Sceletium tortuosum (Zembrin\u00ae) in healthy adults"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_165",
      "type": "Compound",
      "name": "PDE4B",
      "attributes": {
        "context": "Association study of PDE4B with panic disorder"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_166",
      "type": "Indication",
      "name": "panic disorder",
      "attributes": {
        "context": "with panic disorder in the Japanese population"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_167",
      "type": "Taxon",
      "name": "South African Indigenous Plants",
      "attributes": {
        "context": "South African Indigenous Plants used as Remedies"
      },
      "source_chunk_ids": [
        "514fc4680f52d6651e526d3854f60fdd"
      ]
    },
    {
      "id": "ent_168",
      "type": "Compound",
      "name": "Phosphodiesterase type 4 isozymes",
      "attributes": {
        "context": "Phosphodiesterase type 4 isozymes expression"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_169",
      "type": "Compound",
      "name": "[3H]rolipram",
      "attributes": {
        "context": "[3H]rolipram binding autoradiography"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_170",
      "type": "PharmEffect",
      "name": "antidepressant drug action",
      "attributes": {
        "context": "antidepressant drug action"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_171",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "nausea produced by rolipram"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_172",
      "type": "Compound",
      "name": "phosphodiesterase-4 (PDE4) inhibitor",
      "attributes": {
        "context": "rolipram, a phosphodiesterase-4 (PDE4) inhibitor"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_173",
      "type": "PharmEffect",
      "name": "nausea",
      "attributes": {
        "context": "detect nausea produced by rolipram"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_174",
      "type": "Compound",
      "name": "Phosphodiesterase inhibitors",
      "attributes": {
        "context": "Phosphodiesterase inhibitors enhance object memory"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_175",
      "type": "PharmEffect",
      "name": "enhance object memory",
      "attributes": {
        "context": "Phosphodiesterase inhibitors enhance object memory"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_176",
      "type": "Compound",
      "name": "Calcium-independent phosphodiesterase inhibitors",
      "attributes": {
        "context": "Calcium-independent phosphodiesterase inhibitors as putative antidepressants"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_177",
      "type": "PharmEffect",
      "name": "putative antidepressants",
      "attributes": {
        "context": "inhibitors as putative antidepressants"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_178",
      "type": "Compound",
      "name": "[3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones",
      "attributes": {
        "context": "[3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_179",
      "type": "Indication",
      "name": "DSM-IV",
      "attributes": {
        "context": "diagnostic psychiatric interview for DSM-IV"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_180",
      "type": "Indication",
      "name": "ICD-10",
      "attributes": {
        "context": "diagnostic psychiatric interview for DSM-IV and ICD-10"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_181",
      "type": "Taxon",
      "name": "Sceletium tortuosum",
      "attributes": {
        "context": "effects of Sceletium tortuosum"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_182",
      "type": "Indication",
      "name": "psychological stress",
      "attributes": {
        "context": "model of psychological stress"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_183",
      "type": "PharmEffect",
      "name": "Psychoactive",
      "attributes": {
        "context": "Psychoactive constituents of the genus Sceletium"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_184",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "constituents of the genus Sceletium N.E.Br."
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_185",
      "type": "Taxon",
      "name": "Mesembryanthemaceae",
      "attributes": {
        "context": "other Mesembryanthemaceae"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_186",
      "type": "Indication",
      "name": "basolateral amygdala damage",
      "attributes": {
        "context": "after basolateral amygdala damage"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_187",
      "type": "Compound",
      "name": "Testosterone",
      "attributes": {
        "context": "Testosterone reduces amygdala-orbitofrontal cortex coupling"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_188",
      "type": "PharmEffect",
      "name": "reduces amygdala-orbitofrontal cortex coupling",
      "attributes": {
        "context": "Testosterone reduces amygdala-orbitofrontal cortex coupling"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_189",
      "type": "Compound",
      "name": "Progesterone",
      "attributes": {
        "context": "Progesterone selectively increases amygdala reactivity"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_190",
      "type": "PharmEffect",
      "name": "increases amygdala reactivity",
      "attributes": {
        "context": "Progesterone selectively increases amygdala reactivity"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_191",
      "type": "Indication",
      "name": "fear",
      "attributes": {
        "context": "amygdala in fear"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_192",
      "type": "Indication",
      "name": "stress",
      "attributes": {
        "context": "amygdala in fear, stress"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_193",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "stress, and anxiety"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_194",
      "type": "Compound",
      "name": "phosphodiesterase type 4 inhibitor rolipram",
      "attributes": {
        "context": "Administration of the phosphodiesterase type 4 inhibitor rolipram"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_195",
      "type": "PharmEffect",
      "name": "increases recognition memory persistence",
      "attributes": {
        "context": "increases recognition memory persistence"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_196",
      "type": "PharmEffect",
      "name": "antidepressant treatment",
      "attributes": {
        "context": "repeated antidepressant treatment"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    },
    {
      "id": "ent_197",
      "type": "Compound",
      "name": "type 4A phosphodiesterase (PDE4A)",
      "attributes": {
        "context": "treatment of type 4A phosphodiesterase (PDE4A)"
      },
      "source_chunk_ids": [
        "105aa650773263823b523f15c885acb0"
      ]
    }
  ],
  "relationships": [],
  "metadata": {
    "migration_date": "2026-02-02T08:40:03.886070+00:00",
    "original_file": "entities.json"
  }
}